A Phase 1 Study of LY2523355 in Patients with Acute Leukemia.
Phase of Trial: Phase I
Latest Information Update: 22 Nov 2012
At a glance
- Drugs Litronesib (Primary)
- Indications Acute lymphoblastic leukaemia; Acute myeloid leukaemia; Chronic myeloid leukaemia
- Focus Adverse reactions
- 01 Aug 2012 Actual end date Feb 2011 added as reported by ClinicalTrials.gov.
- 01 Aug 2012 Last checked against ClinicalTrials.gov record.
- 19 Nov 2011 Additional lead trial investigator identified as reported by M.D. Anderson Cancer Center record.